vs
ICHOR HOLDINGS, LTD.（ICHR）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
ICHOR HOLDINGS, LTD.的季度营收约是REPLIGEN CORP的1.1倍（$223.6M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs -7.1%，领先13.9%），REPLIGEN CORP同比增速更快（13.6% vs -4.2%），REPLIGEN CORP自由现金流更多（$17.6M vs $5.9M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 5.4%）
Ichor Holdings Ltd.是面向全球半导体制造领域的关键流体输送系统、子系统及相关组件的设计、制造供应商，产品集成于晶圆前端加工设备，为北美、东亚、欧洲的领先半导体设备与芯片厂商提供先进逻辑、存储芯片生产配套支持。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ICHR vs RGEN — 直观对比
营收规模更大
ICHR
是对方的1.1倍
$197.9M
营收增速更快
RGEN
高出17.8%
-4.2%
净利率更高
RGEN
高出13.9%
-7.1%
自由现金流更多
RGEN
多$11.6M
$5.9M
两年增速更快
RGEN
近两年复合增速
5.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $223.6M | $197.9M |
| 净利润 | $-16.0M | $13.3M |
| 毛利率 | 9.4% | 52.5% |
| 营业利润率 | -6.2% | 9.0% |
| 净利率 | -7.1% | 6.7% |
| 营收同比 | -4.2% | 13.6% |
| 净利润同比 | -304.8% | 143.9% |
| 每股收益（稀释后） | $-0.46 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICHRRGEN
| Q4 25 | $223.6M | $197.9M | ||
| Q3 25 | $239.3M | $188.8M | ||
| Q2 25 | $240.3M | $182.4M | ||
| Q1 25 | $244.5M | $169.2M | ||
| Q4 24 | $233.3M | $174.1M | ||
| Q3 24 | $211.1M | $154.9M | ||
| Q2 24 | $203.2M | $154.1M | ||
| Q1 24 | $201.4M | $151.3M |
净利润ICHRRGEN
| Q4 25 | $-16.0M | $13.3M | ||
| Q3 25 | $-22.9M | $14.9M | ||
| Q2 25 | $-9.4M | $14.9M | ||
| Q1 25 | $-4.6M | $5.8M | ||
| Q4 24 | $-3.9M | $-30.3M | ||
| Q3 24 | $-2.8M | $-654.0K | ||
| Q2 24 | $-5.1M | $3.3M | ||
| Q1 24 | $-9.0M | $2.1M |
毛利率ICHRRGEN
| Q4 25 | 9.4% | 52.5% | ||
| Q3 25 | 4.6% | 53.2% | ||
| Q2 25 | 11.3% | 50.0% | ||
| Q1 25 | 11.7% | 53.6% | ||
| Q4 24 | 11.6% | 26.1% | ||
| Q3 24 | 13.2% | 50.0% | ||
| Q2 24 | 12.6% | 49.8% | ||
| Q1 24 | 11.4% | 49.5% |
营业利润率ICHRRGEN
| Q4 25 | -6.2% | 9.0% | ||
| Q3 25 | -8.1% | 8.9% | ||
| Q2 25 | -2.0% | 7.6% | ||
| Q1 25 | -0.5% | 3.9% | ||
| Q4 24 | -0.5% | -17.7% | ||
| Q3 24 | -0.2% | -5.1% | ||
| Q2 24 | -1.1% | 1.0% | ||
| Q1 24 | -1.9% | 1.3% |
净利率ICHRRGEN
| Q4 25 | -7.1% | 6.7% | ||
| Q3 25 | -9.6% | 7.9% | ||
| Q2 25 | -3.9% | 8.2% | ||
| Q1 25 | -1.9% | 3.4% | ||
| Q4 24 | -1.7% | -17.4% | ||
| Q3 24 | -1.3% | -0.4% | ||
| Q2 24 | -2.5% | 2.2% | ||
| Q1 24 | -4.5% | 1.4% |
每股收益（稀释后）ICHRRGEN
| Q4 25 | $-0.46 | $0.24 | ||
| Q3 25 | $-0.67 | $0.26 | ||
| Q2 25 | $-0.28 | $0.26 | ||
| Q1 25 | $-0.13 | $0.10 | ||
| Q4 24 | $-0.11 | $-0.55 | ||
| Q3 24 | $-0.08 | $-0.01 | ||
| Q2 24 | $-0.15 | $0.06 | ||
| Q1 24 | $-0.30 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $98.3M | $767.6M |
| 总债务越低越好 | $123.5M | $542.2M |
| 股东权益账面价值 | $663.9M | $2.1B |
| 总资产 | $942.9M | $2.9B |
| 负债/权益比越低杠杆越低 | 0.19× | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ICHRRGEN
| Q4 25 | $98.3M | $767.6M | ||
| Q3 25 | $92.5M | $748.7M | ||
| Q2 25 | $92.2M | $708.9M | ||
| Q1 25 | $109.3M | $697.2M | ||
| Q4 24 | $108.7M | $757.4M | ||
| Q3 24 | $116.4M | $784.0M | ||
| Q2 24 | $114.3M | $809.1M | ||
| Q1 24 | $102.1M | $780.6M |
总债务ICHRRGEN
| Q4 25 | $123.5M | $542.2M | ||
| Q3 25 | $123.5M | $537.9M | ||
| Q2 25 | $125.0M | — | ||
| Q1 25 | $126.8M | — | ||
| Q4 24 | $128.5M | $525.6M | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $130.2M | — | ||
| Q1 24 | $131.9M | — |
股东权益ICHRRGEN
| Q4 25 | $663.9M | $2.1B | ||
| Q3 25 | $676.2M | $2.1B | ||
| Q2 25 | $694.1M | $2.1B | ||
| Q1 25 | $700.4M | $2.0B | ||
| Q4 24 | $698.3M | $2.0B | ||
| Q3 24 | $697.3M | $2.0B | ||
| Q2 24 | $694.9M | $2.0B | ||
| Q1 24 | $697.2M | $2.0B |
总资产ICHRRGEN
| Q4 25 | $942.9M | $2.9B | ||
| Q3 25 | $966.6M | $2.9B | ||
| Q2 25 | $985.1M | $2.9B | ||
| Q1 25 | $1.0B | $2.9B | ||
| Q4 24 | $995.6M | $2.8B | ||
| Q3 24 | $975.9M | $2.8B | ||
| Q2 24 | $947.7M | $2.9B | ||
| Q1 24 | $957.4M | $2.8B |
负债/权益比ICHRRGEN
| Q4 25 | 0.19× | 0.26× | ||
| Q3 25 | 0.18× | 0.26× | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.18× | — | ||
| Q4 24 | 0.18× | 0.27× | ||
| Q3 24 | 0.19× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.2M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $5.9M | $17.6M |
| 自由现金流率自由现金流/营收 | 2.6% | 8.9% |
| 资本支出强度资本支出/营收 | 1.5% | 4.1% |
| 现金转化率经营现金流/净利润 | — | 1.93× |
| 过去12个月自由现金流最近4个季度 | $-6.3M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ICHRRGEN
| Q4 25 | $9.2M | $25.7M | ||
| Q3 25 | $9.2M | $48.1M | ||
| Q2 25 | $-7.5M | $28.6M | ||
| Q1 25 | $19.0M | $15.0M | ||
| Q4 24 | $-2.5M | $39.2M | ||
| Q3 24 | $8.1M | $49.3M | ||
| Q2 24 | $17.5M | $42.2M | ||
| Q1 24 | $4.8M | $44.7M |
自由现金流ICHRRGEN
| Q4 25 | $5.9M | $17.6M | ||
| Q3 25 | $2.1M | $43.4M | ||
| Q2 25 | $-14.8M | $21.5M | ||
| Q1 25 | $496.0K | $11.4M | ||
| Q4 24 | $-6.9M | $33.6M | ||
| Q3 24 | $2.2M | $42.3M | ||
| Q2 24 | $14.6M | $37.4M | ||
| Q1 24 | $314.0K | $36.4M |
自由现金流率ICHRRGEN
| Q4 25 | 2.6% | 8.9% | ||
| Q3 25 | 0.9% | 23.0% | ||
| Q2 25 | -6.2% | 11.8% | ||
| Q1 25 | 0.2% | 6.8% | ||
| Q4 24 | -3.0% | 19.3% | ||
| Q3 24 | 1.0% | 27.3% | ||
| Q2 24 | 7.2% | 24.3% | ||
| Q1 24 | 0.2% | 24.0% |
资本支出强度ICHRRGEN
| Q4 25 | 1.5% | 4.1% | ||
| Q3 25 | 3.0% | 2.5% | ||
| Q2 25 | 3.0% | 3.9% | ||
| Q1 25 | 7.6% | 2.1% | ||
| Q4 24 | 1.9% | 3.2% | ||
| Q3 24 | 2.8% | 4.5% | ||
| Q2 24 | 1.4% | 3.1% | ||
| Q1 24 | 2.2% | 5.5% |
现金转化率ICHRRGEN
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 3.23× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.57× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 12.70× | ||
| Q1 24 | — | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICHR
| Other | $101.6M | 45% |
| US | $67.4M | 30% |
| Other Countries | $29.7M | 13% |
| Europe | $24.9M | 11% |
RGEN
暂无分部数据
